Financial Regulation

Alvotech and Teva's settlement with Regeneron for an Eylea biosimilar paves the way for a 2026 launch, promising increased competition and lower costs.

A monumental shift in U.S. drug policy as cannabis is rescheduled. See what this means for Verano, Wall Street, and the future of the industry.

Hexnode UEM launches AI-driven automation and enhanced Zero Trust features to help German, Austrian, and Swiss firms navigate strict data laws.

A new report shows record traffic to MEFA's financial aid tools, revealing how Massachusetts families are navigating soaring tuition and new aid rules.

The niche tech firm leverages its correctional expertise to overhaul state hospitals and tackle complex compliance, signaling a major strategic shift.

New exam results show advisors embracing certification as provinces tighten rules on who can offer financial advice, boosting consumer protection.

A new digital passport is reshaping how Dutch banks vet tech partners. Echoworx's FSQS status signals a major shift toward verified trust in cybersecurity.

MetaComp and Stable are building a compliant, high-speed payment network with stablecoins, aiming to disrupt the trillion-dollar cross-border market.

Quebec food distributor Colabor Group fails to secure a financial lifeline, risking creditor protection and threatening a major regional supply chain disruption.

A new tech platform is untangling the web of pharmacy sourcing for wellness clinics, promising to slash costs and administrative headaches. Is this the future?

A major European bank deepens its pact with HUB Cyber Security. We explore why this signals a critical shift in finance, regulation, and cyber defense.

A new partnership aims to bypass slow, costly banking rails, using stablecoins to unlock faster, cheaper global transactions for businesses. Is this the future?

Gemini's new license to offer prediction markets signals a major regulatory shift, but it also wades into a turbulent world of ethical and legal challenges.

Vision Fortune Finance Institute unveils a powerful new data engine for its Nexus AI, aiming to revolutionize financial research by taming data overload.

On Human Rights Day, Ottawa touts global leadership, but a chasm grows between its international promises and the stagnant progress on justice at home.

A crypto fund's nomination for a top award signals a new era for family offices seeking managed risk and high returns in the volatile digital asset market.

LRN appoints Bob Lemmond as CEO, a strategic move signaling a deeper push into data-driven ethics amid rising AI regulations and market complexity.

A new lab system combines speed, multiplexing, and regulatory trust, promising to accelerate drug development and deepen our biological understanding.

Facing an OSC probe and audit delays, the legal tech firm is now seeking court relief, raising red flags for investors about its governance and finances.

As consumer debt soars, a key advocacy group's new data-focused leadership could turn a powerful analytical lens on the role of healthcare and drug prices.